RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Barnes & Noble Education Rallies On Increased Sales In Q1
  2. Analyst On Why Ethereum Flipping Bitcoin Won't Happen Anytime Soon
  3. New Survey Shows Nearly 50% Of Millennials And Gen Z Want Bitcoin, Cryptos In Their Retirement Fund
  4. SEC’s Approval Of Spot Bitcoin ETFs Won’t Be A Game-Changer For Crypto Industry, JPMorgan Strategists Opine
  5. Silo Pharma Soars On Positive Data For Its Arthritis Drug Candidate